X

22nd Century Group
D

XXII

1.50000
USD
0.06
(4.17%)
Market Closed
Volume
372
EPS
-0
Div Yield
-
P/E
-0
Market Cap
3,554,328
Related Instruments
A
ACB
-0.01000
(-0.23%)
4.37000 USD
C
CGC
0.10500
(11.54%)
1.01500 USD
C
CRBP
-0.23500
(-4.46%)
5.03000 USD
C
CRON
-0.03000
(-1.66%)
1.78000 USD
MO
MO
-1.220
(-2.03%)
58.810 USD
PM
PM
-0.610
(-0.38%)
158.100 USD
T
TLRY
-0.00800
(-1.21%)
0.65120 USD
More
News

Title: 22nd Century Group Inc

Sector: Consumer Defensive
Industry: Tobacco
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.